Site navigation

Navigation

Dyspepsia - proton pump inhibitors (replaced by CG17)

The clinical and cost effectiveness of proton pump inhibitors for the treatment of dyspepsia

Summary

This guidance has been replaced by CG17 Dyspepsia: Managing dyspesia in adults in primary care .


Guidance documents

  • No documents found

Implementing this guidance

  • None available

Other information

About this guidance

Technology appraisals TA7

Issued: July 2000

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance